Reports for GE HEALTHCARE CANADA INC

Company Name

GE HEALTHCARE CANADA INC

Totals

Shortage reports

69

Actual shortage: 0 (0%)
Anticipated shortage: 0 (0%)
Avoided shortage: 5 (7%)
Resolved: 64 (93%)

Discontinuation Reports

5

To be discontinued: 0 (0%)
Discontinued: 5 (100%)
Reversed: 0 (0%)

Late reports

0 (0%)

Overdue reports

0 (0%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
VISIPAQUE 270 550MG SOLUTION Resolved 2022-05-27 2023-01-05 161439
VISIPAQUE 270 550MG SOLUTION Resolved 2022-05-27 2023-01-30 161445
VISIPAQUE 270 550MG SOLUTION Resolved 2022-06-03 2023-02-07 161852
VISIPAQUE 320 652MG SOLUTION Resolved 2021-07-30 2021-08-21 143297
VISIPAQUE 320 652MG SOLUTION Resolved 2021-08-18 2021-08-21 144296
VISIPAQUE 320 652MG SOLUTION Resolved 2022-05-13 2023-01-05 160510
VISIPAQUE 320 652MG SOLUTION Resolved 2022-05-13 2023-01-05 160513
VISIPAQUE 320 652MG SOLUTION Resolved 2022-05-13 2023-01-05 160516
VISIPAQUE 320 652MG SOLUTION Resolved 2022-05-13 2023-01-31 160519

Showing 61 to 69 of 69

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
Metastron 37 MBq/mL Solution Discontinued 2018-10-12 2019-02-01 63929
OMNIPAQUE 180 388MG SOLUTION Discontinued 2023-01-31 2023-02-22 182757
OMNIPAQUE 240 518MG SOLUTION Discontinued 2023-01-31 2023-03-18 182760
OMNISCAN 287MG SOLUTION Discontinued 2023-01-31 2023-03-25 182742
THALLOUS CHLORIDE TI 201 INJECTION 37MBq SOLUTION Discontinued 2020-12-04 2021-06-05 129592

Showing 1 to 5 of 5